Literature DB >> 8791264

The plasminogen activation system in melanoma cell lines and in melanocytic lesions.

T J de Vries1, G N van Muijen, D J Ruiter.   

Abstract

A large body of evidence suggests a role for the proteolytic plasminogen activation system in invasion and metastatic spread of tumor cells including melanoma cells. Plasminogen activation by human melanoma cell lines and B16 mouse melanoma cell lines has been extensively studied. Apart from expression of urokinase-type plasminogen activator, melanoma cells differ from cells derived from other tumors in the abundant expression of tissue-type plasminogen activator. The possible role of both types of plasminogen activator in metastatic spread of melanoma cells is discussed. In recent years the localization of mRNAs and proteins of the plasminogen activation system and of related proteins in cutaneous melanocytic tumor progression has been well documented. A possible mechanism for migration of melanoma cells in vivo is suggested.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8791264     DOI: 10.1097/00008390-199604000-00001

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  5 in total

1.  Biologic Activity of Autologous, Granulocyte-Macrophage Colony-Stimulating Factor Secreting Alveolar Soft-Part Sarcoma and Clear Cell Sarcoma Vaccines.

Authors:  John M Goldberg; David E Fisher; George D Demetri; Donna Neuberg; Stephen A Allsop; Catia Fonseca; Yukoh Nakazaki; David Nemer; Chandrajit P Raut; Suzanne George; Jeffrey A Morgan; Andrew J Wagner; Gordon J Freeman; Jerome Ritz; Cecilia Lezcano; Martin Mihm; Christine Canning; F Stephen Hodi; Glenn Dranoff
Journal:  Clin Cancer Res       Date:  2015-03-24       Impact factor: 12.531

2.  Elastin-derived peptides enhance melanoma growth in vivo by upregulating the activation of Mcol-A (MMP-1) collagenase.

Authors:  J Devy; L Duca; B Cantarelli; D Joseph-Pietras; A Scandolera; A Rusciani; L Parent; J Thevenard; S Brassart Pasco; M Tarpin; L Martiny; L Debelle
Journal:  Br J Cancer       Date:  2010-10-19       Impact factor: 7.640

3.  High tPA-expression in primary melanoma of the limb correlates with good prognosis.

Authors:  C M Ferrier; S Suciu; W L van Geloof; H Straatman; A M Eggermont; H S Koops; B B Kroon; F J Lejeune; U R Kleeberg; G N van Muijen; D J Ruiter
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640

4.  Plasmin releases the anti-tumor peptide from the NC1 domain of collagen XIX.

Authors:  Jean-Baptiste Oudart; Sylvie Brassart-Pasco; Alexia Vautrin; Christèle Sellier; Carine Machado; Aurelie Dupont-Deshorgue; Bertrand Brassart; S Baud; Manuel Dauchez; Jean-Claude Monboisse; Dominique Harakat; François-Xavier Maquart; Laurent Ramont
Journal:  Oncotarget       Date:  2015-02-28

5.  Tetranectin as a Potential Biomarker for Stable Coronary Artery Disease.

Authors:  Yanjia Chen; Hui Han; Xiaoxiang Yan; Fenghua Ding; Xiuxiu Su; Haibo Wang; Qiujing Chen; Lin Lu; Ruiyan Zhang; Wei Jin
Journal:  Sci Rep       Date:  2015-12-01       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.